108 related articles for article (PubMed ID: 32548602)
1. Immune Landscape of the B7 and TNFR Families in Oral Squamous Cell Carcinoma.
Ren XY; Chen XJ; Chen XB; Wang CY; Liu Q; Pan X; Zhang SY; Zhang WL; Cheng B
Chin J Dent Res; 2020; 23(2):109-117. PubMed ID: 32548602
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
[TBL] [Abstract][Full Text] [Related]
3. The comprehensive molecular landscape of the immunologic co-stimulator B7 and TNFR ligand receptor families in colorectal cancer: immunotherapeutic implications with microsatellite instability.
Tang J; Jiang W; Liu D; Luo J; Wu X; Pan Z; Ding P; Li Y
Oncoimmunology; 2018; 7(10):e1488566. PubMed ID: 30288357
[TBL] [Abstract][Full Text] [Related]
4. The immune molecular landscape of the B7 and TNFR immunoregulatory ligand-receptor families in head and neck cancer: A comprehensive overview and the immunotherapeutic implications.
Chen YP; Zhang J; Wang YQ; Liu N; He QM; Yang XJ; Sun Y; Ma J
Oncoimmunology; 2017; 6(3):e1288329. PubMed ID: 28405520
[TBL] [Abstract][Full Text] [Related]
5. The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment.
Bolandi N; Derakhshani A; Hemmat N; Baghbanzadeh A; Asadzadeh Z; Afrashteh Nour M; Brunetti O; Bernardini R; Silvestris N; Baradaran B
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639059
[TBL] [Abstract][Full Text] [Related]
6. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.
Wu L; Deng WW; Yu GT; Mao L; Bu LL; Ma SR; Liu B; Zhang WF; Sun ZJ
Cancer Immunol Immunother; 2016 Sep; 65(9):1035-45. PubMed ID: 27383830
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of B7-H6 protein expression in human oral squamous cell carcinoma.
Wang J; Jin X; Liu J; Zhao K; Xu H; Wen J; Jiang L; Zeng X; Li J; Chen Q
J Oral Pathol Med; 2017 Oct; 46(9):766-772. PubMed ID: 28437013
[TBL] [Abstract][Full Text] [Related]
8. The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.
Xiao Y; Li H; Yang LL; Mao L; Wu CC; Zhang WF; Sun ZJ
Dis Markers; 2019; 2019():5421985. PubMed ID: 31089395
[TBL] [Abstract][Full Text] [Related]
9. Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma.
Tsushima F; Tanaka K; Otsuki N; Youngnak P; Iwai H; Omura K; Azuma M
Oral Oncol; 2006 Mar; 42(3):268-74. PubMed ID: 16271509
[TBL] [Abstract][Full Text] [Related]
10. Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo.
Groeger S; Howaldt HP; Raifer H; Gattenloehner S; Chakraborty T; Meyle J
Pathol Oncol Res; 2017 Jan; 23(1):99-110. PubMed ID: 27498988
[TBL] [Abstract][Full Text] [Related]
11. CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity.
Straub M; Drecoll E; Pfarr N; Weichert W; Langer R; Hapfelmeier A; Götz C; Wolff KD; Kolk A; Specht K
Oncotarget; 2016 Mar; 7(11):12024-34. PubMed ID: 26918453
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response.
Chen JT; Chen CH; Ku KL; Hsiao M; Chiang CP; Hsu TL; Chen MH; Wong CH
Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13057-62. PubMed ID: 26438868
[TBL] [Abstract][Full Text] [Related]
13. The role of B7 family molecules in hematologic malignancy.
Greaves P; Gribben JG
Blood; 2013 Jan; 121(5):734-44. PubMed ID: 23223433
[TBL] [Abstract][Full Text] [Related]
14. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.
Wang L; Cao NN; Wang S; Man HW; Li PF; Shan BE
Tumour Biol; 2016 Mar; 37(3):2961-71. PubMed ID: 26411671
[TBL] [Abstract][Full Text] [Related]
15. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
Bregar A; Deshpande A; Grange C; Zi T; Stall J; Hirsch H; Reeves J; Sathyanarayanan S; Growdon WB; Rueda BR
Gynecol Oncol; 2017 Jun; 145(3):446-452. PubMed ID: 28347512
[TBL] [Abstract][Full Text] [Related]
16. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of immune checkpoints in oral squamous cell carcinoma.
Sieviläinen M; Almahmoudi R; Al-Samadi A; Salo T; Pirinen M; Almangush A
Oral Dis; 2019 Sep; 25(6):1435-1445. PubMed ID: 30315712
[TBL] [Abstract][Full Text] [Related]
18. High PD-L1 expression in the tumour cells did not correlate with poor prognosis of patients suffering for oral squamous cells carcinoma: A meta-analysis of the literature.
Troiano G; Caponio VCA; Zhurakivska K; Arena C; Pannone G; Mascitti M; Santarelli A; Lo Muzio L
Cell Prolif; 2019 Mar; 52(2):e12537. PubMed ID: 30443950
[TBL] [Abstract][Full Text] [Related]
19. The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma.
Zhang C; Wang F; Sun N; Zhang Z; Zhang G; Zhang Z; Luo Y; Che Y; Cheng H; Li J; He J
Genes Dis; 2022 Mar; 9(2):415-428. PubMed ID: 35224157
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.
Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J
Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
